1. Home
  2. EBS vs RPAY Comparison

EBS vs RPAY Comparison

Compare EBS & RPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EBS
  • RPAY
  • Stock Information
  • Founded
  • EBS 1998
  • RPAY 2006
  • Country
  • EBS United States
  • RPAY United States
  • Employees
  • EBS 900
  • RPAY N/A
  • Industry
  • EBS Biotechnology: Pharmaceutical Preparations
  • RPAY Business Services
  • Sector
  • EBS Health Care
  • RPAY Consumer Discretionary
  • Exchange
  • EBS Nasdaq
  • RPAY Nasdaq
  • Market Cap
  • EBS 353.9M
  • RPAY 387.2M
  • IPO Year
  • EBS 2006
  • RPAY N/A
  • Fundamental
  • Price
  • EBS $6.39
  • RPAY $4.82
  • Analyst Decision
  • EBS Strong Buy
  • RPAY Buy
  • Analyst Count
  • EBS 3
  • RPAY 9
  • Target Price
  • EBS $14.33
  • RPAY $8.06
  • AVG Volume (30 Days)
  • EBS 1.3M
  • RPAY 1.4M
  • Earning Date
  • EBS 08-05-2025
  • RPAY 08-07-2025
  • Dividend Yield
  • EBS N/A
  • RPAY N/A
  • EPS Growth
  • EBS N/A
  • RPAY N/A
  • EPS
  • EBS N/A
  • RPAY N/A
  • Revenue
  • EBS $965,400,000.00
  • RPAY $309,647,000.00
  • Revenue This Year
  • EBS N/A
  • RPAY N/A
  • Revenue Next Year
  • EBS $18.88
  • RPAY $8.28
  • P/E Ratio
  • EBS N/A
  • RPAY N/A
  • Revenue Growth
  • EBS N/A
  • RPAY 2.26
  • 52 Week Low
  • EBS $4.02
  • RPAY $3.59
  • 52 Week High
  • EBS $15.10
  • RPAY $10.60
  • Technical
  • Relative Strength Index (RSI)
  • EBS 60.32
  • RPAY 51.27
  • Support Level
  • EBS $6.53
  • RPAY $4.65
  • Resistance Level
  • EBS $6.98
  • RPAY $4.86
  • Average True Range (ATR)
  • EBS 0.35
  • RPAY 0.17
  • MACD
  • EBS 0.01
  • RPAY -0.03
  • Stochastic Oscillator
  • EBS 84.04
  • RPAY 26.83

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

About RPAY Repay Holdings Corporation

Repay Holdings Corp is engaged in providing integrated payment processing solutions to verticals that have transaction processing needs. It allows customers to pay through Mobile App, Text, Interactive Voice Response, Virtual Terminal, Hosted Payment Page and Online Customer Portal among others. It operates in two segments Consumer Payments and Business Payments.

Share on Social Networks: